Schlunk Siegfried, Byram Brett
Vanderbilt University, Nashville, Tennessee, United States.
J Med Imaging (Bellingham). 2024 Sep;11(5):057001. doi: 10.1117/1.JMI.11.5.057001. Epub 2024 Oct 23.
Early image quality metrics were often designed with clinicians in mind, and ideal metrics would correlate with the subjective opinion of practitioners. Over time, adaptive beamformers and other post-processing methods have become more common, and these newer methods often violate assumptions of earlier image quality metrics, invalidating the meaning of those metrics. The result is that beamformers may "manipulate" metrics without producing more clinical information.
In this work, Smith et al.'s signal-to-noise ratio (SNR) metric for lesion detectability is considered, and a more robust version, here called generalized SNR (gSNR), is proposed that uses generalized contrast-to-noise ratio (gCNR) as a core. It is analytically shown that for Rayleigh distributed data, gCNR is a function of Smith et al.'s (and therefore can be used as a substitution). More robust methods for estimating the resolution cell size are considered. Simulated lesions are included to verify the equations and demonstrate behavior, and it is shown to apply equally well to data.
gSNR is shown to be equivalent to SNR for delay-and-sum (DAS) beamformed data, as intended. However, it is shown to be more robust against transformations and report lesion detectability more accurately for non-Rayleigh distributed data. In the simulation included, the SNR of DAS was , and minimum variance (MV) was , but the gSNR of DAS was , and MV was , which agrees with the subjective assessment of the image. Likewise, the transformation (which is clinically identical to DAS) had an incorrect SNR of and a correct gSNR of . Similar results are shown .
Using gCNR as a component to estimate gSNR creates a robust measure of lesion detectability. Like SNR, gSNR can be compared with the Rose criterion and may better correlate with clinical assessments of image quality for modern beamformers.
早期的图像质量指标通常是为临床医生设计的,理想的指标应与从业者的主观意见相关。随着时间的推移,自适应波束形成器和其他后处理方法变得越来越普遍,而这些新方法常常违反早期图像质量指标的假设,使这些指标的意义失效。结果是波束形成器可能会“操纵”指标,却没有产生更多的临床信息。
在这项研究中,考虑了史密斯等人用于病变可检测性的信噪比(SNR)指标,并提出了一个更稳健的版本,这里称为广义信噪比(gSNR),它以广义对比噪声比(gCNR)为核心。分析表明,对于瑞利分布的数据,gCNR是史密斯等人指标的函数(因此可以用作替代)。考虑了更稳健的估计分辨单元大小的方法。纳入模拟病变以验证公式并展示其行为,结果表明该方法对数据同样适用。
如预期的那样,gSNR对于延迟求和(DAS)波束形成的数据等同于SNR。然而,对于非瑞利分布的数据,它在抵抗变换方面表现得更稳健,并且能更准确地报告病变可检测性。在包含的模拟中,DAS的SNR为 ,最小方差(MV)为 ,但DAS的gSNR为 ,MV为 ,这与图像的主观评估结果一致。同样, 变换(在临床上与DAS相同)的SNR错误地为 ,而正确的gSNR为 。展示了类似的结果。
使用gCNR作为估计gSNR的一个组成部分,可以创建一个稳健的病变可检测性度量。与SNR一样,gSNR可以与罗斯准则进行比较,并且对于现代波束形成器,它可能与图像质量的临床评估具有更好的相关性。